Dana-Farber Cancer Institute
Scientists find regulator linking exercise to bigger, stronger muscles
Scientists at Dana-Farber Cancer Institute have isolated a previously unknown protein in muscles that spurs their growth and increased power following resistance exercise. They suggest that artificially raising the protein's ...
Medical research
Dec 06, 2012 |
5 / 5 (7) |
0
|
Finally: A male contraceptive pill in the making?
The development of a male contraceptive pill has long proven to be elusive, but findings from a new study may point scientists in the right direction to making oral birth control for men a reality.
Medical research
Aug 16, 2012 |
4.3 / 5 (6) |
2
|
Scientists find molecular link to obesity and insulin resistance in mice
Flipping a newly discovered molecular switch in white fat cells enabled mice to eat a high-calorie diet without becoming obese or developing the inflammation that causes insulin resistance, report scientists ...
Medical research
Sep 27, 2012 |
5 / 5 (5) |
0
|
Scientists find potential loophole in pancreatic cancer defenses
Dana-Farber Cancer Institute scientists and colleagues have discovered that pancreatic cancer cells' growth and spread are fueled by an unusual metabolic pathway that someday might be blocked with targeted drugs to control ...
Cancer
Mar 27, 2013 |
5 / 5 (4) |
0
|
Newly isolated 'beige fat' cells could help fight obesity
Scientists at Dana-Farber Cancer Institute have isolated a new type of energy-burning fat cell in adult humans which they say may have therapeutic potential for treating obesity.
Medical research
Jul 12, 2012 |
5 / 5 (3) |
0
|
New strategy prevents rheumatoid arthritis in mice
Dana-Farber Cancer Institute scientists have demonstrated a new strategy for treating autoimmune disease that successfully blocked the development of rheumatoid arthritis in a mouse model. They say it holds promise for improved ...
Arthritis & Rheumatism
Feb 08, 2013 |
5 / 5 (3) |
0
|
US cancer death rates continue to decline, national report finds
A report from the nation's leading cancer organizations shows rates of death in the United States from all cancers for men and women continued to decline between 2000 and 2009. The findings come from the latest Annual Report ...
Cancer
Jan 08, 2013 |
4.3 / 5 (3) |
1
New drug strategy attacks resistant leukemia and lymphoma
Scientists at the Dana-Farber/Children's Hospital Cancer Center have developed an anti-cancer peptide that overcomes the stubborn resistance to chemotherapy and radiation often encountered in certain blood cancers when the ...
Cancer
May 29, 2012 |
5 / 5 (2) |
0
Hormone-depleting drug shows promise against localized high-risk prostate tumors
A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, ...
Cancer
May 16, 2012 |
5 / 5 (1) |
0
Study reports first success of targeted therapy in type of non-small cell lung cancer
A novel compound has become the first targeted therapy to benefit patients with the most common genetic subtype of lung cancer, an international clinical trial led by scientists at Dana-Farber Cancer Institute and other institutions ...
Cancer
May 31, 2012 |
5 / 5 (1) |
0
New tool determines leukemia cells' 'readiness to die,' may guide clinical care
Researchers at Dana-Farber Cancer Institute have developed a novel method for determining how ready acute myeloid leukemia (AML) cells are to die, a discovery that may help cancer specialists to choose treatments option more ...
Cancer
Oct 11, 2012 |
5 / 5 (1) |
0
|
Targeting cancers' 'addiction' to cell-cycle proteins shuts down tumors in mice
In what they say is a promising and highly selective treatment strategy, scientists at Dana-Farber Cancer Institute have safely shut down breast cancer and a form of leukemia in mice by targeting abnormal proteins to which ...
Cancer
Oct 16, 2012 |
5 / 5 (1) |
0
New drug overcomes resistance in patients with rare sarcoma
A new targeted drug demonstrated its ability to control metastatic gastrointestinal stromal tumor, an uncommon and life-threatening form of sarcoma, after the disease had become resistant to all existing therapies, report ...
Cancer
Nov 21, 2012 |
5 / 5 (1) |
0
|
Study tracks leukemia's genetic evolution, may help predict disease course, tailor care
Tumors are not factories for the mass production of identical cancer cells, but are, in reality, patchworks of cells with different patterns of gene mutations. In a new study, researchers at Dana-Farber Cancer Institute and ...
Cancer
Feb 14, 2013 |
5 / 5 (1) |
0
Some patients with incurable tumors and BRCA mutations respond to new two-drug combination
A novel combination of two drugs has shown anti-cancer activity in patients who had incurable solid tumors and carried a germline mutation in their BRCA genes, Dana-Farber Cancer Institute researchers are reporting at the ...
Cancer
Apr 07, 2013 |
5 / 5 (1) |
0
